Growing Bearish Pressure on NVAX
Novavax (NVAX) is experiencing a notable surge in short-selling activity. Recent data indicates that the stock's squeeze score has jumped significantly from 73.5 to 84.2, reflecting a rapid increase in bearish sentiment. With 32.3% of the float currently sold short, NVAX is among the most heavily shorted stocks in the current market environment.
Liquidity and Risk
The days-to-cover ratio for NVAX is currently 5.3, suggesting that it would take over five days of average trading volume for short sellers to fully cover their positions. This level of short interest, combined with the rising squeeze score, highlights a high-risk environment for traders. While the borrow fee remains at 0.4%, the sheer volume of shares held short makes NVAX a critical ticker to watch for potential short-covering rallies.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.